Malaria is a communicable disease, transmitted from person to person through the bite of infected Anopheles mosquitoes. It falls squarely in the category of vector-borne communicable diseases, meaning the pathogen does not jump directly between humans through casual contact, coughing, or touching, but instead relies on a biological middleman. That intermediary role of the mosquito, combined with the fact that you cannot “catch” malaria from sitting next to someone who has it, is probably what causes some confusion about how to classify the disease.
What Makes a Disease Communicable
A communicable disease is one caused by an infectious agent that can be transmitted between hosts, whether directly or indirectly. The chain of transmission has three basic links: a source of infection (an infected human or animal), a route of transmission (air, water, bodily fluids, or a vector like a mosquito), and a susceptible host. Malaria checks every box. The parasite, a single-celled organism in the genus Plasmodium, circulates in the blood of infected people. A female Anopheles mosquito picks up the parasite during a blood meal, the parasite matures inside the mosquito, and the mosquito injects it into the next person it bites. Vector-borne diseases like malaria, dengue, and Lyme disease are classified alongside airborne and waterborne infections as communicable diseases because the infectious agent passes between living hosts.1Wiley Online Library. Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies
Noncommunicable diseases, by contrast, are conditions that cannot be passed from one person to another. Heart disease, diabetes, cancer, and chronic respiratory diseases are the big examples. They arise from a mix of genetic, behavioral, and environmental factors rather than from infection by a transmissible pathogen. The distinction matters because it shapes how public health systems respond: communicable diseases call for surveillance, isolation, vector control, and treatment of carriers to break the chain, while noncommunicable diseases demand long-term management, lifestyle interventions, and screening programs.
The Mosquito Is Not Optional (Usually)
The overwhelming majority of malaria infections worldwide start with a mosquito bite. The parasite’s life cycle is exquisitely adapted to this arrangement. Inside the human bloodstream, Plasmodium produces specialized sexual stages called gametocytes, whose sole purpose is to be picked up by a mosquito during feeding.2PubMed Central. Biology of Malaria Transmission Inside the mosquito’s gut, the gametocytes mate and eventually produce a form of the parasite that migrates to the salivary glands, ready to be injected into the next human. Without the mosquito to serve as both incubator and delivery system, the parasite’s sexual cycle cannot complete, and new infections cannot arise through the normal route.
This tight dependence on the mosquito is why malaria control has historically focused so heavily on mosquito elimination and bite prevention. It also explains why malaria does not behave like the flu: you will not get it from a handshake, a sneeze, or sharing a drink. You need an infected mosquito, or one of the much rarer alternative routes described below.
When Malaria Spreads Without a Mosquito
Although the mosquito route dominates, malaria can pass between people through other mechanisms, and these reinforce its classification as communicable rather than weaken it. Three alternative transmission pathways are well documented.
The first is congenital transmission. A pregnant woman carrying Plasmodium parasites in her blood can pass the infection to her unborn child across the placenta. Several physiological barriers normally reduce this risk, including the placental structure itself and the protective effect of fetal hemoglobin, so congenital malaria is relatively uncommon.3Journal of Travel Medicine. Congenital Malaria in Non-Endemic Settings: A Literature Review and Update on Diagnosis and Management In regions where malaria is widespread and many pregnant women carry the parasite, molecular detection methods are picking up congenital infections more frequently than was previously recognized.4PubMed. Congenital malaria: the least known consequence of malaria in pregnancy In the United States and other non-endemic countries, congenital malaria is rare but not unheard of, as illustrated by cases in infants born to mothers who recently emigrated from endemic areas.5PubMed Central. Congenital Plasmodium falciparum Malaria in Washington, DC
The second route is blood-borne transmission through shared needles. Because the malaria parasite lives in red blood cells, injecting even a small amount of infected blood can establish an infection. One outbreak investigation in Iran found that all 27 patients who tested positive for Plasmodium falciparum had shared needles and syringes before falling ill. No Anopheles mosquitoes were found within a kilometer of the site, and there had been no prior malaria transmission in the area, effectively ruling out a mosquito source.6PubMed. Outbreak investigation of needle sharing-induced malaria, Ahvaz, Iran Blood transfusion and organ transplantation carry the same theoretical risk, which is why blood banks in many countries screen donors for malaria exposure.
These non-mosquito routes are epidemiologically minor compared to vector transmission, but they matter medically. A doctor evaluating a feverish newborn in a non-endemic country might not think of malaria unless they know about the congenital route. And public health programs in areas with injection drug use need to account for the possibility of needle-transmitted malaria even where mosquitoes are not the problem.
The Silent Reservoir Problem
One feature that makes malaria’s communicability harder to control than it might seem is the existence of asymptomatic carriers. In regions where malaria transmission is intense, many people harbor Plasmodium parasites in their bloodstream without feeling sick. These individuals still carry gametocytes that a feeding mosquito can pick up, so they contribute to ongoing transmission even though they never visit a clinic or take treatment.7PubMed Central. Hidden reservoirs of infection: prevalence and risk factors of asymptomatic malaria in a high-endemic region of Zambia
How infectious these carriers actually are to mosquitoes varies. Research in Cambodia found that none of the asymptomatic carriers of P. falciparum and only a small fraction of P. vivax carriers successfully infected mosquitoes in feeding experiments.8PubMed. Contribution to Malaria Transmission of Symptomatic and Asymptomatic Parasite Carriers in Cambodia That does not mean asymptomatic carriers are irrelevant, though. In highly endemic regions, the sheer number of asymptomatic individuals means that even a low per-person probability of infecting a mosquito adds up. Elimination programs that treat only symptomatic cases will leave this silent reservoir intact, which is one of the biggest obstacles to driving malaria cases to zero.
Relapses and the Dormant Liver Stage
Plasmodium vivax and its close relative P. ovale add another wrinkle to the communicability story. Unlike P. falciparum, which causes the most deadly form of malaria, P. vivax can hide in the liver in a dormant stage called a hypnozoite. These sleeping parasites can reactivate weeks, months, or even years after the original mosquito bite, producing a fresh wave of blood-stage infection and symptoms.9PubMed Central. Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine P. vivax’s ability to persist in dormancy has been confirmed in laboratory models, where hypnozoites activated to produce blood-stage parasites long after the initial infection.10Cell Host & Microbe. Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
This matters for communicability because a person who was infected in an endemic country can relapse after moving to a non-endemic area. If local Anopheles mosquitoes are present, and in parts of southern Europe, the Korean peninsula, and portions of the Americas they are, that relapsing individual could theoretically seed local transmission. For the person themselves, a relapse feels like a new bout of malaria, but it traces back to the original infective bite. Standard antimalarial drugs that clear blood-stage parasites do not kill hypnozoites; that requires specific treatment with drugs like primaquine or tafenoquine. Incomplete treatment leaves the door open for future relapses and continued communicability.
Why Some People Are Partly Protected
The fact that malaria has exerted enormous selective pressure on human populations for thousands of years has left genetic footprints that affect how communicable the disease is in practice. The best-known example is the sickle cell trait. Carrying one copy of the sickle hemoglobin gene (HbS) provides meaningful protection against severe malaria, a relationship that researchers have progressively confirmed over decades.11PubMed Central. Sickle cell protection from malaria The picture is not entirely straightforward, however. A study in Guinea-Bissau found that sickle cell trait carriers were actually more likely to test positive for P. falciparum infection in cross-sectional surveys, but among infected children under five, those with sickle cell trait had lower parasite densities and higher hemoglobin levels, suggesting the trait limits the severity of infection rather than preventing it outright.12PubMed. Association between sickle cell trait and Plasmodium falciparum infection: evidence for age-specific protection in a cross-sectional study in Guinea-Bissau
Other genetic variants, including different thalassemias and glucose-6-phosphate dehydrogenase deficiency, show similar patterns of partial protection. None of these traits make someone immune. They shift the odds, reducing the likelihood of severe illness and death but not eliminating infection or the ability to transmit parasites onward. In malaria-endemic populations, these inherited traits are common precisely because they confer a survival advantage in the face of relentless transmission. The coexistence of sickle cell trait with alpha thalassemia can actually diminish the protective effect, which may explain why the sickle cell trait is less prevalent in some Mediterranean populations than in sub-Saharan Africa.11PubMed Central. Sickle cell protection from malaria
Misconceptions About How Malaria Spreads
Despite decades of public health messaging, misunderstandings about malaria transmission persist even in communities where the disease is a daily threat. A survey of pregnant women in displacement camps in northern Uganda found that while roughly 80 percent correctly identified mosquito bites as the mode of transmission, substantial numbers attributed malaria to cold weather, dirt, not sleeping under a net, eating cold food, playing in the rain, or eating mangoes.13PubMed Central. Knowledge and Misconceptions about Malaria among Pregnant Women in a Post-Conflict Internally Displaced Persons’ Camps in Gulu District, Northern Uganda Some of these beliefs echo older pre-scientific ideas. The very word “malaria” comes from the Italian for “bad air,” reflecting the centuries-old miasma theory that diseases were spread by foul-smelling vapors from swamps and decaying matter.14PubMed Central. Ronald Ross: Pioneer of Malaria Research and Nobel Laureate The theory was not entirely wrong in its practical implications: avoiding swampy areas did reduce malaria exposure, even though the mechanism was the mosquitoes breeding there, not the air itself.
These misconceptions are not just trivia. If a community believes malaria comes from eating certain foods or getting rained on, they may take fewer precautions against mosquito bites and be less likely to support vector control measures. Accurate knowledge that malaria is a communicable disease transmitted by mosquitoes is one of the foundations of effective prevention.
Breaking the Transmission Chain
Because malaria is communicable and depends on a vector, the most effective interventions target the link between mosquito and human. Insecticide-treated bed nets are the most widely used tool. Mathematical modeling and field evidence show that bed nets provide both personal protection to the person sleeping under them and communal protection to the broader population, since they kill mosquitoes that contact the treated netting, reducing the overall mosquito population and the proportion of infectious mosquitoes in the area.15Nature Communications. Quantifying the direct and indirect protection provided by insecticide treated bed nets against malaria Even people who do not sleep under a net benefit from reduced mosquito numbers when their neighbors do.16PubMed Central. Insecticide-treated nets can reduce malaria transmission by mosquitoes which feed outdoors
Achieving malaria elimination in a given area means interrupting local transmission entirely, driving new cases to zero.17PubMed Central. Enhancing malaria elimination in high-transmission settings: the synergy of concurrent vector control and chemotherapy That requires tackling every part of the transmission chain simultaneously: killing or repelling mosquitoes, treating infected individuals so they stop carrying gametocytes, and addressing the hidden reservoir of asymptomatic carriers. In high-transmission settings, no single tool is sufficient on its own; successful elimination campaigns combine vector control with mass drug administration or other chemotherapy strategies.
The Double Burden in Sub-Saharan Africa
Malaria’s classification as communicable has practical consequences for how countries allocate health resources. Sub-Saharan Africa, which bears roughly 96 percent of global malaria deaths, is simultaneously facing a rise in noncommunicable diseases like diabetes, heart disease, and cancers.18PubMed Central. Temporal trends in the burden of non-communicable diseases in countries with the highest malaria burden, 1990-2019: Evaluating the double burden of non-communicable and communicable diseases in epidemiological transition Health systems in these countries are being asked to fight malaria with vector control and treatment programs while also building chronic disease management infrastructure for conditions that require lifelong care. The two categories of disease demand different types of health system capacity, and funding streams are often separate, creating competition for limited resources.
This double burden also complicates individual patient care. A person living with diabetes who contracts malaria faces worse outcomes than a healthy individual. Malaria-induced inflammation and metabolic disruption can destabilize blood sugar control, while some antimalarial drugs interact with medications used to manage chronic conditions. The communicable and noncommunicable categories are tidy on paper, but inside a real patient, they collide.
Climate Change and Shifting Mosquito Ranges
Where malaria can be transmitted is not fixed. As global temperatures rise, the geographic range of Anopheles mosquitoes is shifting, and areas that were previously too cold for the mosquitoes or the parasite to survive are becoming suitable for transmission.19PubMed Central. A Scoping Review of Mosquito Vector Range Shifts: Widespread Expansions and Evidence Gaps in Climate Attribution P. vivax already develops inside mosquitoes at lower temperatures than P. falciparum, which partly explains why vivax malaria historically extended into temperate regions where falciparum could not gain a foothold.
Modeling work in Brazil illustrates the concern. Under high-emission climate scenarios, the suitable habitat for a key malaria vector species along the Atlantic coast was projected to increase by more than 75 percent near 20 large cities, with roughly half of Brazil’s population living in areas of expanding suitability.20PubMed. Climate change impacts on Anopheles (K.) cruzii in urban areas of Atlantic Forest of Brazil: Challenges for malaria diseases The dynamics are further complicated by the presence of non-human primates that can harbor Plasmodium parasites, creating a wildlife reservoir that could sustain transmission even when human cases are driven down. Researchers in the Brazilian Atlantic Forest have documented spillover and spillback of malaria parasites between humans, mosquitoes, and howler monkeys, illustrating a transmission web far more tangled than the simple human-mosquito-human chain.21Current Research in Parasitology & Vector-Borne Diseases. Complexity of malaria transmission dynamics in the Brazilian Atlantic Forest
For populations in highland regions of East Africa, parts of South America, and even southern Europe, the question of whether malaria is communicable in their community may shift from theoretical to very personal in the coming decades, as warming temperatures invite mosquitoes into places they have never been before.